Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRI-KEV Trial
NCT07765667Phase 2Not yet recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in rectal adenocarcinoma, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ascorbic acid
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT07765667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765667.